These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23293895)

  • 21. The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation.
    Zhu J; Ji X; Xu Y; Liu J; Miao YY; Zhang JA; Luo D; Zhou BR
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27862727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides.
    Bulstrode NW; Grobbelaar AO
    Aesthetic Plast Surg; 2002; 26(5):356-9. PubMed ID: 12432474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acromegaly is associated with decreased skin transepidermal water loss and temperature, and increased skin pH and sebum secretion partially reversible after treatment.
    Borlu M; Karaca Z; Yildiz H; Tanriverdi F; Demirel B; Elbuken G; Cakir I; Dokmetas HS; Colak R; Unluhizarci K; Kelestimur F
    Growth Horm IGF Res; 2012 Apr; 22(2):82-6. PubMed ID: 22436513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
    Fabi SG; Sundaram H; Guiha I; Goldman MP
    J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach.
    Campanati A; Giuliodori K; Giuliano A; Martina E; Ganzetti G; Marconi B; Chiarici A; Offidani A
    Arch Dermatol Res; 2013 Oct; 305(8):691-7. PubMed ID: 23800969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.
    Ascher B; Zakine B; Kestemont P; Baspeyras M; Bougara A; Santini J
    J Am Acad Dermatol; 2004 Aug; 51(2):223-33. PubMed ID: 15280841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of microneedle fractional radiofrequency therapy with intradermal botulinum toxin a injection for periorbital rejuvenation.
    Jeon IK; Chang SE; Park GH; Roh MR
    Dermatology; 2013; 227(4):367-72. PubMed ID: 24280617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study.
    Gassner HG; Brissett AE; Otley CC; Boahene DK; Boggust AJ; Weaver AL; Sherris DA
    Mayo Clin Proc; 2006 Aug; 81(8):1023-8. PubMed ID: 16901024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treated patients in survey: High satisfaction with botulinum toxin in palmar hyperhidrosis].
    Deebaj R; Emtestam L; Lundeberg L; Brandin Samuelsson K; Girnita A
    Lakartidningen; 2015 Jan; 112():. PubMed ID: 25625725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneedle delivery of botulinum toxin type A combined with hyaluronic acid for the synergetic management of multiple sternal keloids with oily skin: A retrospective clinical investigation.
    Zhang S; Peng Y; Fan H; Zhang Y; Min P
    J Cosmet Dermatol; 2022 Nov; 21(11):5601-5609. PubMed ID: 35796638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and instrumental study of the efficacy of a new sebum control cream.
    Dobrev H
    J Cosmet Dermatol; 2007 Jun; 6(2):113-8. PubMed ID: 17524128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
    Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines.
    Glogau R; Blitzer A; Brandt F; Kane M; Monheit GD; Waugh JM
    J Drugs Dermatol; 2012 Jan; 11(1):38-45. PubMed ID: 22206075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
    Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies.
    Bowler PJ
    J Cosmet Dermatol; 2008 Sep; 7(3):241-4. PubMed ID: 18789065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R; Shome D; Jain V; Dikshit R
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea.
    Bloom BS; Payongayong L; Mourin A; Goldberg DJ
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S9-16. PubMed ID: 25548852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.